Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
02/2009
02/04/2009CN100457118C 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
02/03/2009US7485733 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle
02/03/2009US7485727 4-Phenoxy-, 4-phenylthio-, 4-phenylsulfonyl- or 5-phenylsulfinyl-1-(2-pyridinyl)piperidine derivatives; insecticides, miticides and nematocides
02/03/2009US7485724 2,4-pyrimidinediamine compounds and their uses
02/03/2009US7485664 Inhibitors of TACE
02/03/2009US7485657 Anti-cytokine heterocyclic compounds
02/03/2009US7485652 Indolyl derivatives as liver-X-receptor (LXR) modulators
02/03/2009US7485643 Bicyclic inhibitors of MEK and methods of use thereof
02/03/2009US7485637 Benzoyl-tetrahydropiperidine derivatives
02/03/2009US7485636 Therapeutic pyrazolo[3,4-b]pyridines and indazoles
02/03/2009CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists
02/03/2009CA2382435C Novel herbicidally active phenyl-substituted heterocycles
02/03/2009CA2334821C Chemical synthesis of morpholine derivatives
02/03/2009CA2315050C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof
01/2009
01/29/2009WO2009015254A1 Triazine kinase inhibitors
01/29/2009WO2009014910A2 N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders
01/29/2009WO2009014637A2 Heterocyclic amide compounds as protein kinase inhibitors
01/29/2009WO2009014217A1 Bicyclic pyrrole derivative
01/29/2009WO2009014100A1 p27 PROTEIN INDUCER
01/29/2009WO2009013195A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
01/29/2009WO2008118379A3 AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
01/29/2009US20090030198 Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
01/29/2009US20090030197 Quinoline Intermediates of Receptor Tyrosine Kinase Inhibitors and the Synthesis Thereof
01/29/2009US20090030195 2-Oxo-3-[1-oxo-3-(2-trifluoromethylphenyl)-1,2-dihydroisoquinolin-7-yl]oxazolidin-5-ylmethyl(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)acetate; 7-(2-Oxoazetidin-1-yl)-3-(2-trifluoromethylphenyl)-2H-isoquinolin-1-one; anticarcinogenic agent ( solid cancer)
01/29/2009US20090030051 Inhibitors of IMPDH enzyme
01/29/2009US20090030050 Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
01/29/2009US20090030016 Benzimidazole poly(adp ribose)polymerase inhibitors
01/29/2009US20090030008 Piperazine derivatives and their use as therapeutic agents
01/29/2009US20090030000 Antiviral agents
01/29/2009US20090029998 Thiazole Derivatives and Use Thereof
01/29/2009US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors
01/29/2009US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
01/29/2009US20090029994 Trisubstituted amine compound
01/29/2009US20090029992 Substituted pyrazole compounds
01/29/2009US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors
01/29/2009US20090029989 Substituted pyrazolopyrimidines
01/29/2009US20090029988 Hydroxyalkyl Substituted Imidazoquinolines
01/29/2009US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
01/29/2009US20090029981 Substituted 4-phenylpiperidines
01/29/2009US20090029977 Dual modulators of 5ht2a and d3 receptors
01/29/2009US20090029976 e.g. [5-(1-cyclobutyl-piperidin-yloxy)-benzofuran-2-yl]-(4,4-difluoro-piperidin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor (H3 receptor); antidepressant, antiepileptic agent, analgesic, anticonvulsant, motion seackness
01/29/2009US20090029963 Pyrazol derivatives
01/29/2009US20090029863 Pesticides and uses thereof
01/29/2009US20090028815 Diazabenzo[De]anthracen-3-one Compounds and Methods for Inhibiting Parp
01/29/2009US20090028787 Novel Heteroaryl Substituted Benzothiazoles
01/29/2009US20090026928 Made by reacting an N,N'-diarylbenzidine with a 2-bromo-5-phenylphenothiazine or 3-bromo-10-phenylphenoxazine to form corresponding N,N'-bis-(phenoxazine or phenothiazine)-N,N'-diphenylbenzidine; OLEDs; hole injection layer or a hole transport layer; thermal stability
01/29/2009DE102007035367A1 Substituierte Aryloxazole und ihre Verwendung Substituted Aryloxazole and their use
01/29/2009CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity
01/29/2009CA2694009A1 Dual modulators of 5-ht2a and d3 receptors
01/29/2009CA2693967A1 Heterocyclic amide compounds as protein kinase inhibitors
01/29/2009CA2693377A1 5-pyridinone substituted indazoles
01/29/2009CA2693207A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
01/29/2009CA2693169A1 N-linked heterocyclic receptor agonists for the treatment of metabolic disorders
01/28/2009EP2019094A1 Heterocyclic type cinnamide derivative
01/28/2009EP2018792A2 Substituted piperidino phenyloxazolidinones
01/28/2009EP2018375A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
01/28/2009EP2018371A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/28/2009EP2018370A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
01/28/2009EP2018167A2 Compositions and methods for fgf receptor kinases inhibitors
01/28/2009EP1177181B1 Substituted bicyclic compounds
01/28/2009CN101356171A N4-phenyl-quinaz0line-4-amine derivatives and related compounds as ERBBI type receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
01/28/2009CN101356169A 吡嗪衍生物 Pyrazine derivatives
01/28/2009CN101353313A Process to produce oxazolidinones
01/27/2009US7482466 Hydroxamates as therapeutic agents
01/27/2009US7482465 Indol derivatives and their use as 5-HT ligands
01/27/2009US7482456 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
01/27/2009US7482448 Compounds and compositions as cathepsin inhibitors
01/27/2009US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders
01/27/2009US7482366 Modulators of LXR
01/27/2009US7482355 Pyrimidine derivatives as modulators of chemokine receptor activity
01/27/2009US7482347 CCR-3 receptor antagonists; inflammatory or allergic condition such as asthma or obstructive airway disease; 1-[1-(3,5-Dimethylisoxazole-4-sulfonyl)-piperdin-4-yl-methyl]-4-(4-fluorobenzyl)-piperazine; 1-(4-Fluorobenzyl)-4-(4-piperidinylmethyl) piperazine intermediate and a sulfonyl halide reactant
01/27/2009US7482344 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure
01/27/2009US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors
01/27/2009US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
01/27/2009CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
01/27/2009CA2377226C Benzimidazole compounds and medicaments comprising the same
01/27/2009CA2377126C Thiazole and oxazole derivatives and their pharmaceutical use
01/27/2009CA2361187C A process for the preparation of taxanes from 10-deacetylbaccatin iii
01/27/2009CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
01/27/2009CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
01/25/2009WO2009078694A1 Formulations comprising an asphaltene-dispersing/-inhibiting additive based on oxazolidines derived from polyalkyl or polyalkenyl n-hydroxyalkyl succinimides
01/25/2009CA2708368A1 Formulations comprising an asphaltene-dispersing/inhibiting additive based on oxazolidines derived from polyalkyl or polyalkenyl n-hydroxyalkyl succinimides
01/22/2009WO2009012421A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
01/22/2009WO2009012283A1 Compounds and methods for kinase modulation, and indications therefor
01/22/2009WO2009012252A1 Aminoalkylazole derivatives as histamine-3 antagonists
01/22/2009WO2009012242A2 Sodium channel inhibitors
01/22/2009WO2009012125A1 Compounds and methods for modulating fxr
01/22/2009WO2009011880A2 Heterocyclic modulators of pkb
01/22/2009WO2009011627A1 Pyridine compounds and their use as p2y12 antagonists
01/22/2009WO2009010784A1 New compounds 955
01/22/2009WO2009010479A2 Heterocyclic methylene piperidine derivatives and their use
01/22/2009WO2009010478A2 Use of piperidine derivatives as agonists of chemokine receptor activity
01/22/2009WO2009010260A2 Condensed anthranilamide insecticides
01/22/2009WO2008142550A3 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
01/22/2009WO2008130021A3 Heterocyclic hydrazide compound and pesticidal use of the same
01/22/2009WO2007136465A3 Compositions and methods for fgf receptor kinases inhibitors
01/22/2009US20090023918 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
01/22/2009US20090023779 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
01/22/2009US20090023733 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them
01/22/2009US20090023732 Citrate Salt of an Indole Derivative and its Pharmaceutical Use